![George Creatsas's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places George Creatsas's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places](https://www.researchgate.net/publication/329433189/figure/fig2/AS:1086470517465108@1636046165386/Regression-analysis-line-graph-of-variables-BDNF-pg-ml-and-fetal-growth-centile-a_Q320.jpg)
George Creatsas's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
RESEARCH ARTICLE Red Blood Cell Transfusions in Greece: Results of a Survey of Red Blood Cell Use in 2013
ResearchTJH-2016-0188.R2 Submitted: 24 May 2016 Accepted: 15 November 2016 RED BLOOD CELLS TRANSFUSION IN GREECE: RESULTS OF A S
![George Creatsas's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places George Creatsas's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places](https://www.researchgate.net/publication/329433189/figure/fig1/AS:1086470517469213@1636046165265/BDNF-mean-values-pg-ml-and-95-confidence-intervals-comparison-between-groups-1SGA_Q320.jpg)
George Creatsas's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places
![Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI ... Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI ...](https://ar.iiarjournals.org/content/anticanres/42/2/1031/F2.large.jpg)
Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI ...
![Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI ... Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI ...](https://ar.iiarjournals.org/content/anticanres/42/2/1031/F1.large.jpg)